Coeptis Therapeutics Holdings, Inc.
COEP
Revenue
0.00
0.000.00%
3 Months ChangeAssets
4.20M
▲304.10k▲7.81%
3 Months ChangeLiabilities
4.51M
▼-526.48k▼-10.46%
3 Months ChangeFree Cash Flow
-1.68M
▼-722.74k▼-75.15%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-30
Form 8-K
ID: 0001683168-24-006763
2024-09-19
Form 8-K
ID: 0001683168-24-006521
2024-08-16
Form 10-Q
ID: 0001683168-24-005799
2024-08-14
Form 8-K
ID: 0001683168-24-005713
2024-07-31
Form 8-K
ID: 0001683168-24-005183
2024-06-20
Form 8-K
ID: 0001683168-24-004361
2024-05-10
Form 10-Q
ID: 0001683168-24-003228
2024-03-25
Form 8-K
ID: 0001683168-24-001672
2024-02-01
Form 8-K
ID: 0001683168-24-000615
2023-12-22
Form 8-K
ID: 0001683168-23-009058